Can you guess the U.S. preterm birth rate?

Study reveals rising use of antiseizure medications during pregnancy, highlighting risks and trends in maternal health and medication safety.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.

A new review finds immediate release nifedipine offers comparable safety and efficacy to IV labetalol and hydralazine in managing severe hypertension during pregnancy.

A new study finds that patient-reported screening methods are highly effective for determining medication abortion eligibility.